Mar 04, 2021 / 01:45PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-End 2020 Financial Results and Corporate Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Pam Murphy. Thank you. Please go ahead, ma'am.
Pam Murphy - Arbutus Biopharma Corporation - IR Consultant
Good morning, and thank you for joining the Arbutus Biopharma Fourth Quarter 2020 Conference Call and Webcast. On the call today are Bill Collier, President and Chief Executive Officer; Dr. Gaston Picchio, Chief Development Officer; Dr. Michael Sofia, Chief Scientific Officer; and Dave Hastings, Chief Financial Officer. Bill will begin with a summary of recent accomplishments and upcoming events and a review of Arbutus' 2021 corporate objective, followed by Gaston, Mike Sofia and Dave Hastings, who will provide clinical drug discovery and financial updates, respectively. Please note Gaston
Q4 2020 Arbutus Biopharma Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot